Neuroendocrine Tumour (NET) Unit
Our private Neuroendocrine tumour (NET) unit services are provided at the Royal Free Hospital, Hampstead .
To find out more about our hospitals click here
The neuroendocrine tumour (NET) unit at the Royal Free Hospital – Private Patients Unit has an international reputation for the management of neuroendocrine tumour patients.
Founded in 1997, our Neuroendocrine Tumour (NET) Unit is currently the largest globally, with approximately 2,500 patients under regular follow-ups. Our large clinical research program has international collaborations.
The aim of the Royal Free Hospital – Private Patients Unit neuroendocrine tumour group is to provide optimal management for patients with neuroendocrine tumours, taking into account how the tumour affects each individual.
We work within a multidisciplinary team and aim to enhance the prospects for treatment by a combination of clinical and laboratory research. The RFH PPU NET unit and oncology department conducts a number of clinical and basic science research trials relating to the treatment of and the pathogenesis of NET development.
The NET unit clinicians and researchers collaborate with clinicians and research staff in the UK and abroad. The clinical lead and head of the neuroendocrine unit is Professor Martyn Caplin.
What do we offer?
World class care, convenience, comfort and personalised attention
We work within a multidisciplinary team and aim to enhance the prospects for treatment by a combination of clinical and laboratory research. The unit and oncology department conducts a number of clinical and basic science research trials relating to the treatment of and the pathogenesis of NET development.
NET Multi-disciplinary Team (MDT) consisting of:
- 3 dedicated Gastroenterologists
- 2 Oncologists
- 2 Endocrinologists
- 2 Hepato-Biliary-Pancreatic (HPB) Surgeons
- 2 Colorectal Surgeons
- 1 Cardiologist
- 1 Lung Physician
- 3 Nuclear Medicine Physicians
- 3 Radiologists
- 2 Histopathologists,
- 3 dedicated NET specialist Nurses
- and a dedicated NET Dietician
Lead consultant
Professor Christos Toumpanakis
Professor Christos Toumpanakis is a Consultant in Gastroenterology & Neuroendocrine Tumours in the Centre for Gastroenterology & Neuroendocrine Tumour Unit – ENETS Centre of Excellence of Royal Free Hospital, London.
Prof Toumpanakis is leading a NET clinical research group and his main research interests include novel biomarkers and molecular imaging in NETs, mesenteric fibrosis and carcinoid heart disease.
